Clinical trials
Recruiting Carcinoma, Intraductal, Noninfiltrating trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Fudan University | 2 |
| M.D. Anderson Cancer Center | 2 |
| Thomas Jefferson University | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Finn, Olivera, PhD | 1 |
| Glendale Adventist Medical Center d/b/a Adventist Health Glendale | 1 |
| HeroSupport SA | 1 |
| Hoag Memorial Hospital Presbyterian | 1 |
| Incheon St.Mary's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Intraductal, Noninfiltrating | 39 |
| Breast Neoplasms | 23 |
| Breast Carcinoma In Situ | 8 |
| Carcinoma, Ductal, Breast | 2 |
| COVID-19 | 1 |
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 |
| Hereditary Breast and Ovarian Cancer Syndrome | 1 |
| Neoplastic Syndromes, Hereditary | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.